Kolexia
Negrier Claude Médecine générale
Negrier Claude
Médecine générale
Hôpital Louis Pradel
Bron, France
273 Activités
84 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Hémorragie Hémophilie B Troubles de l'hémostase et de la coagulation Maladies de von Willebrand Thrombose Afibrinogénémie Troubles de l'hémostase Maladies articulaires

Collaborateurs

Voir plus
Dargaud Yesim
Dargaud Yesim
Hôpital Louis Pradel, Bron, France
Lambert Thierry
Lambert Thierry
Hôpital Bicêtre, Le Kremlin-Bicêtre, France
Lienhart Anne
Lienhart Anne
Hôpital Louis Pradel, Bron, France
Nougier Christophe
Nougier Christophe
Hôpital Femme Mère Enfant, Bron, France

Industries

Voir plus
Takeda Pharmaceutical
17 collaboration(s)
Dernière en 2021
Roche
16 collaboration(s)
Dernière en 2021
Sobi
14 collaboration(s)
Dernière en 2022
Bayer
13 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
HAVEN 6: A Multicenter, Open-Label Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Emicizumab in Patients With Mild or Moderate Hemophilia A Without FVIII Inhibitors
Essai Clinique (Roche)   08 mars 2024
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis (ATLAS-PPX).
Blood   07 mars 2024
Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia.
Gene therapy   14 février 2024
Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks.
Research and practice in thrombosis and haemostasis   29 décembre 2023
A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one-stage clotting and chromogenic substrate assays at clinical haemostasis laboratories.
Haemophilia : the official journal of the World Federation of Hemophilia   30 octobre 2023
Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults.
Research and practice in thrombosis and haemostasis   22 août 2023
Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study.
Therapeutic advances in hematology   24 juillet 2023
Hémophilie
HAS Publications   20 juin 2023
TRANSHEMO: Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   13 février 2023
PO018 EFANESOCTOCOG ALFA ACTIVITY ASSESSMENT WITH ONE-STAGE CLOTTING (OSA) AND CHROMOGENIC SUBSTRATE (CSA) FACTOR VIII ASSAYS
16th Annual Congress of European Association for Haemophilia and Allied Disorders 2023, 7–10 February 2023, Manchester   05 février 2023